Lorazepam and Fluorometholone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lorazepam (lorazepam) and Fluorometholone (fluorometholone). Common drug interactions include hepatic enzyme increased among females and herpes zoster among males.

The phase IV clinical study analyzes what interactions people have when they take Lorazepam and Fluorometholone. It is created by eHealthMe based on reports of 98 people who take the same drugs from the FDA, and is updated regularly.

What is Lorazepam?

Lorazepam has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,639 Lorazepam users. Check the latest studies of Lorazepam.

What is Fluorometholone?

Fluorometholone has active ingredients of fluorometholone. eHealthMe is studying from 2,628 Fluorometholone users. Check the latest studies of Fluorometholone.



On Jul, 11, 2026

98 people who take Lorazepam and Fluorometholone together, and have interactions are studied.

Lorazepam and Fluorometholone drug interactions.

What are the common drug interactions of Lorazepam and Fluorometholone, by gender? *:

female:

  1. Hepatic enzyme increased
  2. Hypercholesterolaemia (high levels of cholesterol in the blood)
  3. Hypersensitivity
  4. Hypertension (high blood pressure)
  5. Hysterectomy
  6. Ill-defined disorder
  7. Infection
  8. Joint swelling
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Mobility decreased (ability to move is reduced)

male:

  1. Herpes zoster
  2. Arthralgia (joint pain)
  3. Ageusia (loss of taste functions of the tongue)
  4. Coccydynia (pain in the coccyx or tailbone area)
  5. Cytomegalovirus infection
  6. Depression
  7. Failure to thrive (inadequate weight gain and physical growth in children)
  8. Full blood count decreased
  9. Joint stiffness
  10. Lacrimal disorder (disease of lacrimal duct)

What are the common drug interactions of Lorazepam and Fluorometholone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Anti-cyclic citrullinated peptide antibody positive
  2. Arthralgia (joint pain)
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  4. Arthropathy
  5. Asthenia (weakness)
  6. Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
  7. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  8. Blood cholesterol increased
  9. Bone erosion
  10. Breast cancer stage iii

50-59:

  1. Body temperature decreased
  2. Chronic kidney disease
  3. Renal failure (kidney dysfunction)
  4. Abdominal pain upper
  5. Blood pressure decreased
  6. Cough
  7. Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
  8. Fatigue (feeling of tiredness)
  9. Heart rate increased
  10. Infusion related reaction

60+:

  1. Constipation
  2. Fatigue (feeling of tiredness)
  3. Impaired healing
  4. Malignant neoplasm progression (cancer tumour came back)
  5. Mass
  6. Metastatic renal cell carcinoma (spreadable kidney cell tumour)
  7. Muscular weakness (muscle weakness)
  8. Pneumonia
  9. Pulmonary embolism (blockage of the main artery of the lung)
  10. Rash

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 19 people, 19.39%
  2. High Blood Pressure: 10 people, 10.20%
  3. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 10 people, 10.20%
  4. Joint Pain: 9 people, 9.18%
  5. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 9 people, 9.18%
  6. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 8 people, 8.16%
  7. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 8 people, 8.16%
  8. Constipation: 8 people, 8.16%
  9. Psoriasis (immune-mediated disease that affects the skin): 8 people, 8.16%
  10. Multiple Myeloma (cancer of the plasma cells): 7 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Lorazepam and Fluorometholone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lorazepam and Fluorometholone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lorazepam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Fluorometholone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lorazepam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fluorometholone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lorazepam and fluorometholone (the active ingredients of Lorazepam and Fluorometholone, respectively), and Lorazepam and Fluorometholone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: